Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study is a single site double blinded Phase II study to evaluate the chemopreventative effectiveness of vismodegib in the treatment of subjects at high risk for developing basal cell carcinomas (BCC).
Epistemonikos ID: ab75e964d195f7e181e17e514df4c051d95761e0
First added on: May 11, 2024